Abstract
Visceral leishmaniasis (VL) is the most severe form of leishmaniasis and results from parasitic infection by certain species of the protozoan genus Leishmania. Because VL is often fatal unless treated, rapid and accurate diagnosis of the disease is indispensable for case control. Currently, the gold standard diagnosis of VL is detection of parasites in a spleen or bone marrow aspirate. Because this method is invasive, time-consuming, and not sufficiently sensitive, rendering it inefficient, alternative methods including serological diagnosis have been developed. The first generation serological tests that detect antibodies to Leishmania parasites in peripheral blood, serum or plasma, have utilized crude antigen, e.g., whole parasites or parasite lysate, that often have cross-reactivity / low specificity issues. As a result, efforts have been focused on characterizing antigens for second generation diagnostic tests. The best example of such defined antigens is the recombinant K39 protein, or rK39, which contains a 39-amino acid repeat, and diagnostic tests based on this antigen are now commercially available and used world-wide. This review discusses advances in and the current status on antigen discovery for antibody detection-type diagnostic tests of visceral leishmaniasis.
Keywords: Visceral leishmaniasis, diagnosis, antigen discovery
Current Chemical Biology
Title: Antigen Discovery for Serological Diagnosis of Visceral Leishmaniasis
Volume: 4 Issue: 3
Author(s): Yasuyuki Goto and Steven G. Reed
Affiliation:
Keywords: Visceral leishmaniasis, diagnosis, antigen discovery
Abstract: Visceral leishmaniasis (VL) is the most severe form of leishmaniasis and results from parasitic infection by certain species of the protozoan genus Leishmania. Because VL is often fatal unless treated, rapid and accurate diagnosis of the disease is indispensable for case control. Currently, the gold standard diagnosis of VL is detection of parasites in a spleen or bone marrow aspirate. Because this method is invasive, time-consuming, and not sufficiently sensitive, rendering it inefficient, alternative methods including serological diagnosis have been developed. The first generation serological tests that detect antibodies to Leishmania parasites in peripheral blood, serum or plasma, have utilized crude antigen, e.g., whole parasites or parasite lysate, that often have cross-reactivity / low specificity issues. As a result, efforts have been focused on characterizing antigens for second generation diagnostic tests. The best example of such defined antigens is the recombinant K39 protein, or rK39, which contains a 39-amino acid repeat, and diagnostic tests based on this antigen are now commercially available and used world-wide. This review discusses advances in and the current status on antigen discovery for antibody detection-type diagnostic tests of visceral leishmaniasis.
Export Options
About this article
Cite this article as:
Goto Yasuyuki and G. Reed Steven, Antigen Discovery for Serological Diagnosis of Visceral Leishmaniasis, Current Chemical Biology 2010; 4 (3) . https://dx.doi.org/10.2174/2212796811004030225
DOI https://dx.doi.org/10.2174/2212796811004030225 |
Print ISSN 2212-7968 |
Publisher Name Bentham Science Publisher |
Online ISSN 1872-3136 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Role of Cytokines in the Pathophysiology of Acute Graft-Versus-Host Disease (GVHD)– Are Serum/Plasma Cytokines Potential Biomarkers for Diagnosis of Acute GVHD Following Allogeneic Hematopoietic Cell Transplantation (Allo-HCT)?
Current Stem Cell Research & Therapy Adamantane – A Lead Structure for Drugs in Clinical Practice
Current Medicinal Chemistry Large Granular Lymphocyte (LGL) Leukemia: Pathobiology, Diagnosis and Treatment
Current Cancer Therapy Reviews Recombinant Salmonella Vaccination Technology and Its Application to Human Bacterial Pathogens
Current Pharmaceutical Biotechnology Atopic Dermatitis and Cytokines: Recent Patents in Immunoregulatory and Therapeutic Implications of Cytokines in Atopic Dermatitis - Part I: Cytokines in Atopic Dermatitis
Recent Patents on Inflammation & Allergy Drug Discovery Exploring and Exploiting Microbial Diversity through Metagenomics for Natural Product Drug Discovery
Current Topics in Medicinal Chemistry Targeting Upstream Kinases of STAT3 in Human Medulloblastoma Cells
Current Cancer Drug Targets Current Updates in the Medical Management of Obesity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Cannabis Abuse and Vulnerability to Psychosis: Targeting Preventive Services
Current Pharmaceutical Design Vitamins B1, B2, B3 and B9 – Occurrence, Biosynthesis Pathways and Functions in Human Nutrition
Mini-Reviews in Medicinal Chemistry The Insulin-like Growth Factor-1 Axis and its Potential as a Therapeutic Target in Central Nervous System (CNS) Disorders
Central Nervous System Agents in Medicinal Chemistry Monoclonal Antibodies and their Target Specificity Against SARS-CoV-2 Infections: Perspectives and Challenges
Recent Patents on Biotechnology Canine Nutritional Model: Influence of Age, Diet, and Genetics on Health and Well-Being
Current Nutrition & Food Science Telomere G-Quadruplex as a Potential Target to Accelerate Telomere Shortening by Expanding the Incomplete End-Replication of Telomere DNA
Current Topics in Medicinal Chemistry Which Dose of Folic Acid Should Pregnant Diabetic Women Receive?
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Multitarget Network Strategies to Influence Memory and Forgetting: The Ras/Mapk Pathway as a Novel Option
Mini-Reviews in Medicinal Chemistry How Recent Patents Have Changed our Clinical Approach in Cardio-Thoracic Surgery
Recent Patents on Regenerative Medicine Telomere Maintenance as Therapeutic Target in Embryonal Tumours
Anti-Cancer Agents in Medicinal Chemistry The Metabolic Syndrome and HIV Infection
Current Pharmaceutical Design T Cell Redirecting Therapies for Cancer Treatment
Current Cancer Drug Targets